CIK 0001232524 · Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- EIN
- 981032470
- Phone
- 353-1-634-7800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- 4 Open-market sale SVP, Chief Accounting Officer sold 163 shares at $108.83 ($17,738)
- 144 Insider Sale of Securities
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Executive or director change
- 4 Open-market sale EVP & Chief Legal Officer sold 5,000 shares at $109.65 ($548,250)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 10-K/A Report 10-K/A
- 4 Shares withheld for taxes President & COO gave up 1,736 shares (to pay taxes)
- 4 Open-market sale SVP, Chief Accounting Officer sold 3,704 shares at an average $118.37 ($438,448)
- 4 Shares withheld for taxes President & COO gave up 3,622 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Head of Europe & Internat gave up 2,474 shares (to pay taxes)
- 4 Shares withheld for taxes EVP & Chief Legal Officer gave up 3,432 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Global Head of R&D gave up 4,294 shares (to pay taxes)
- 4 Shares withheld for taxes Chairman & CEO gave up 22,436 shares (to pay taxes)
- 144 Insider Sale of Securities
- 4 Grant or award SVP, Technical Operations acquired 5,178 shares (grant or award)
- 4 Grant or award SVP, Chief Accounting Officer acquired 2,987 shares (grant or award)
- 4 Grant or award SVP, Head of Europe & Internat acquired 5,065 shares (grant or award)
Page 18 of 110 · 2,194 filings